TMEM69

gene
On this page

Also known as FLJ21029

Summary

TMEM69 (transmembrane protein 69, HGNC:28035) is a protein-coding gene on chromosome 1p34.1, encoding Transmembrane protein 69 (Q5SWH9).

Located in mitochondrion.

Source: NCBI Gene 51249 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 41 total
  • MANE Select transcript: NM_016486

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28035
Approved symbolTMEM69
Nametransmembrane protein 69
Location1p34.1
Locus typegene with protein product
StatusApproved
AliasesFLJ21029
Ensembl geneENSG00000159596
Ensembl biotypeprotein_coding
Entrez51249

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 16 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000372025, ENST00000496366, ENST00000871190, ENST00000871191, ENST00000871192, ENST00000871193, ENST00000871194, ENST00000871195, ENST00000871196, ENST00000871197, ENST00000937789, ENST00000937790, ENST00000937791, ENST00000937792, ENST00000937793, ENST00000937794, ENST00000960165

RefSeq mRNA: 1 — MANE Select: NM_016486 NM_016486

CCDS: CCDS41325

Canonical transcript exons

ENST00000372025 — 3 exons

ExonStartEnd
ENSE000014567264569320445694436
ENSE000014567274569097445691110
ENSE000019237584568818145688275

Expression profiles

Bgee: expression breadth ubiquitous, 255 present calls, max score 98.28.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 49.6438 / max 313.1952, expressed in 1818 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
270547.10041817
27042.5434754

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002398.28gold quality
secondary oocyteCL:000065598.18gold quality
epithelial cell of pancreasCL:000008396.29gold quality
left ventricle myocardiumUBERON:000656694.91gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.74gold quality
gingival epitheliumUBERON:000194993.59gold quality
myocardiumUBERON:000234993.11gold quality
germinal epithelium of ovaryUBERON:000130492.73gold quality
esophagus squamous epitheliumUBERON:000692092.55gold quality
rectumUBERON:000105292.38gold quality
ileal mucosaUBERON:000033192.28gold quality
gingivaUBERON:000182892.28gold quality
cardiac muscle of right atriumUBERON:000337992.13gold quality
vastus lateralisUBERON:000137992.03gold quality
palpebral conjunctivaUBERON:000181291.97gold quality
quadriceps femorisUBERON:000137791.81gold quality
deltoidUBERON:000147691.73gold quality
penisUBERON:000098991.53gold quality
biceps brachiiUBERON:000150791.31gold quality
monocyteCL:000057691.12gold quality
islet of LangerhansUBERON:000000691.08gold quality
leukocyteCL:000073890.96gold quality
hindlimb stylopod muscleUBERON:000425290.67gold quality
esophagus mucosaUBERON:000246990.64gold quality
cortical plateUBERON:000534390.50gold quality
right adrenal glandUBERON:000123390.39gold quality
pigmented layer of retinaUBERON:000178290.23gold quality
right adrenal gland cortexUBERON:003582790.22gold quality
metanephrosUBERON:000008190.13gold quality
lower esophagus mucosaUBERON:003583489.95gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.23

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): GLI1

miRNA regulators (miRDB)

42 targeting TMEM69, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-656-3P100.0072.152788
HSA-MIR-366299.9973.825684
HSA-MIR-477599.9875.006394
HSA-MIR-1213699.9872.815713
HSA-MIR-548N99.9871.944170
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-211099.9666.681930
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-130599.9171.433443
HSA-MIR-568099.9169.833421
HSA-MIR-427199.8868.322244
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-806799.8669.592260
HSA-MIR-444799.8567.812900
HSA-MIR-3681-5P99.8266.88387
HSA-MIR-139-5P99.8069.501399
HSA-MIR-498-5P99.7669.641807
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-6849-5P99.6466.00352
HSA-MIR-80299.6167.701254
HSA-MIR-129099.5969.902079
HSA-MIR-1212399.5271.792990
HSA-MIR-1211799.5067.57868
HSA-MIR-203A-3P99.4970.562806
HSA-MIR-143-3P99.4969.051457
HSA-MIR-477099.4969.091451
HSA-MIR-608899.2968.451284

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotmem69ENSDARG00000076017
mus_musculusTmem69ENSMUSG00000055900
rattus_norvegicusTmem69ENSRNOG00000029152

Protein

Protein identifiers

Transmembrane protein 69Q5SWH9 (reviewed: Q5SWH9)

All UniProt accessions (1): Q5SWH9

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

RefSeq proteins (1): NP_057570* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR021836DUF3429Family

Pfam: PF11911

UniProt features (7 total): transmembrane region 5, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5SWH9-F173.680.40

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 108 (showing top): AAAYRNCTG_UNKNOWN, YY1_Q6, MYOD_01, chr1p34, LYF1_01, DODD_NASOPHARYNGEAL_CARCINOMA_UP, RYTTCCTG_ETS2_B, YY1_01, ACTWSNACTNY_UNKNOWN, GCCATNTTG_YY1_Q6, MYB_Q6, SMAD4_Q6, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): mitochondrion (GO:0005739), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cytoplasm1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

488 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM69GPBP1L1Q9HC44741
TMEM69CCDC137Q6PK04649
TMEM69ZC3H10Q96K80601
TMEM69CBLN3Q6UW01581
TMEM69CLEC19AQ6UXS0549
TMEM69C1QTNF7Q9BXJ2531
TMEM69PECRQ9BY49521
TMEM69DNLZQ5SXM8479
TMEM69ENTR1Q96C92477
TMEM69METAP1P53582476
TMEM69TXNDC12O95881473
TMEM69LRRC20Q8TCA0464
TMEM69MRGPRX3Q96LB0464
TMEM69PURGQ9UJV8464
TMEM69MAST2Q6P0Q8461

IntAct

11 interactions, top by confidence:

ABTypeScore
TUSC5TMEM69psi-mi:“MI:0915”(physical association)0.560
TMEM69TMEM14Bpsi-mi:“MI:0915”(physical association)0.560
AQP6TMEM69psi-mi:“MI:0915”(physical association)0.560
TMEM69ACOX3psi-mi:“MI:0914”(association)0.350
TUSC5TMEM69psi-mi:“MI:0915”(physical association)0.000
TMEM14BTMEM69psi-mi:“MI:0915”(physical association)0.000
TMEM69AQP6psi-mi:“MI:0915”(physical association)0.000
TMEM69TMEM14Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (20): TMEM69 (Two-hybrid), TMEM69 (Two-hybrid), TUSC5 (Two-hybrid), IMPACT (Affinity Capture-MS), ACOX3 (Affinity Capture-MS), PKLR (Affinity Capture-MS), PBK (Affinity Capture-MS), KLK3 (Affinity Capture-MS), PRTN3 (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), RTFDC1 (Affinity Capture-MS), SMEK1 (Affinity Capture-MS), TPP2 (Affinity Capture-MS), S100A2 (Affinity Capture-MS)

ESM2 similar proteins: A1XQS5, A6H666, A8XDX2, B0VYY5, B3DHU2, G5EDB8, O14046, P00842, P05496, P07926, P10175, P11432, P16000, P16221, P17605, P23968, P32876, P48201, P48772, P56383, P56384, Q01931, Q03672, Q06055, Q06056, Q06645, Q06646, Q0V9J0, Q0VCH8, Q2LCR3, Q2TA24, Q37315, Q3ZC75, Q53CG1, Q59550, Q5RAP9, Q5RFL2, Q5SWH9, Q71S46, Q7JX57

Diamond homologs: Q0V9J0, Q3KQJ0, Q5SWH9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

41 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance27
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

358 predictions. Top by Δscore:

VariantEffectΔscore
1:45688259:TCTCA:Tdonor_gain0.9800
1:45693198:TTGTA:Tacceptor_loss0.9800
1:45693199:TGTAG:Tacceptor_loss0.9800
1:45693201:TA:Tacceptor_loss0.9800
1:45693202:A:AGacceptor_gain0.9800
1:45693202:AGAT:Aacceptor_loss0.9800
1:45693203:G:Cacceptor_loss0.9800
1:45693203:G:GGacceptor_gain0.9800
1:45693203:GAT:Gacceptor_gain0.9700
1:45693192:T:Gacceptor_gain0.9300
1:45690972:A:AGacceptor_gain0.9200
1:45690973:G:GGacceptor_gain0.9200
1:45693203:GATA:Gacceptor_gain0.9200
1:45688255:C:Tdonor_gain0.9100
1:45688309:T:TAdonor_gain0.9100
1:45688310:A:AAdonor_gain0.9100
1:45688158:G:GTdonor_gain0.8900
1:45688189:G:GTdonor_gain0.8900
1:45690973:GAAAC:Gacceptor_gain0.8900
1:45693203:GA:Gacceptor_gain0.8800
1:45688226:T:TAdonor_gain0.8700
1:45693203:GATAC:Gacceptor_gain0.8200
1:45693184:T:TAacceptor_gain0.8100
1:45689000:TTC:Tdonor_gain0.7800
1:45689067:C:Gdonor_gain0.7600
1:45693191:A:AGacceptor_gain0.7400
1:45690973:GA:Gacceptor_gain0.7300
1:45691105:TCAAA:Tdonor_loss0.7200
1:45691106:CAAAG:Cdonor_loss0.7200
1:45691107:AAAG:Adonor_loss0.7200

AlphaMissense

1603 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:45693564:A:CS135R0.988
1:45693566:T:AS135R0.988
1:45693566:T:GS135R0.988
1:45693594:T:AW145R0.979
1:45693594:T:CW145R0.979
1:45693654:A:CS165R0.978
1:45693656:T:AS165R0.978
1:45693656:T:GS165R0.978
1:45693678:T:AW173R0.970
1:45693678:T:CW173R0.970
1:45693600:T:CF147L0.961
1:45693602:T:AF147L0.961
1:45693602:T:GF147L0.961
1:45693789:T:AW210R0.951
1:45693789:T:CW210R0.951
1:45693576:T:CF139L0.950
1:45693578:C:AF139L0.950
1:45693578:C:GF139L0.950
1:45693438:A:CS93R0.947
1:45693440:C:AS93R0.947
1:45693440:C:GS93R0.947
1:45693735:G:CG192R0.946
1:45693596:G:CW145C0.938
1:45693596:G:TW145C0.938
1:45693555:T:GY132D0.936
1:45693736:G:AG192D0.935
1:45693505:T:GM115R0.928
1:45693597:G:CG146R0.927
1:45693685:C:AA175D0.924
1:45693559:G:AG133E0.920

dbSNP variants (sampled 300 via entrez): RS1000154561 (1:45687547 G>C,T), RS1000540441 (1:45692377 A>AT), RS1000574232 (1:45691411 C>T), RS1000658036 (1:45692115 C>A,G,T), RS1001023908 (1:45686704 A>G), RS1001855994 (1:45686965 C>G,T), RS1001990501 (1:45686767 G>A,C), RS1002451210 (1:45692975 G>A), RS1002646293 (1:45689034 G>A), RS1002920718 (1:45691569 G>A), RS1003030075 (1:45691820 G>A), RS1003088194 (1:45686325 C>A,T), RS1003477400 (1:45686984 C>T), RS1003532308 (1:45688027 G>C), RS1003668178 (1:45687853 G>A,C,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST005951_37Body mass index8.000000e-10
GCST009391_1592Metabolite levels5.000000e-06
GCST010696_7Cortical thickness (min-P)3.000000e-08
GCST010697_28Cortical surface area (min-P)2.000000e-08
GCST010698_30Subcortical volume (min-P)3.000000e-08
GCST010699_45Brain morphology (min-P)3.000000e-08
GCST010700_23Cortical thickness (MOSTest)1.000000e-10
GCST010701_9Cortical surface area (MOSTest)2.000000e-08
GCST010702_139Subcortical volume (MOSTest)4.000000e-14
GCST010703_258Brain morphology (MOSTest)2.000000e-13

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0010376phosphatidylcholine 34:2 measurement
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression3
Air Pollutantsdecreases expression, affects expression, increases abundance2
aristolochic acid Idecreases expression1
GSK-J4decreases expression1
di-n-butylphosphoric acidaffects expression1
ICG 001decreases expression1
Acetaminophendecreases expression1
Air Pollutants, Occupationaldecreases expression1
Cisplatinincreases expression1
Doxorubicindecreases expression1
Leadaffects expression1
Nickeldecreases expression1
Ozoneaffects expression, increases abundance1
Asbestos, Crocidolitedecreases expression1
Antirheumatic Agentsdecreases expression1
Particulate Matterdecreases expression, increases abundance1

Cellosaurus cell lines

3 cell lines: 3 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2IUAbcam HeLa TMEM69 KOCancer cell lineFemale
CVCL_B5L4HAP1 TMEM69 (-) 2Cancer cell lineMale
CVCL_XU53HAP1 TMEM69 (-) 1Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.